Bevacizumab Inhibits Angiogenic Cytokines in Head and Neck Squamous Cell Carcinoma: From Gene to the Protein

https://cmfrc.tums.ac.ir/article/Bevacizumab-Inhibits-Angiogenic-Cytokines-in-Head-and-Neck-Squamous-Cell-Carcinoma:-From-Gene-to-the-Protein

bevacizumab, a vascular endothelial growth (VEGF) factor monoclonal antibody on HNSCC cells in vitro to evaluate angiogenic profile changes. Materials and Methods: HNSCC cells were grown and after that different concentrations of bevacizumab were added in...